Mark E. Duggan
Impact in
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Cell Adhesion Molecules Research 20
-
- Neuroscience and Neuropharmacology Research 16
- Co-authors
- George D. Hartman (29 shared papers)Michele H. Potashman (1 shared paper)Craig W. Lindsley (17 shared papers)Zhijian Zhao (5 shared papers)Joel R. Huff (5 shared papers)Hans E. Huber (4 shared papers)R. Robinson (4 shared papers)Raymond E. Jones (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (23 papers)Journal of Medicinal Chemistry (14 papers)Neuropharmacology (2 papers)ACS Medicinal Chemistry Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesUnited KingdomFinland
In The Last Decade
Mark E. Duggan
61 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 93
- Immunology and Allergy 485
- Cellular and Molecular Neuroscience 612
- Molecular Biology 1.3k
- Organic Chemistry 680
- Computational Theory and Mathematics 259
Countries citing papers authored by Mark E. Duggan
This map shows the geographic impact of Mark E. Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Duggan more than expected).
Fields of papers citing papers by Mark E. Duggan
This network shows the impact of papers produced by Mark E. Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Duggan. The network helps show where Mark E. Duggan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Duggan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 446 | |
| 2 | 2009 | 301 | |
| 3 | 1992 | 264 | |
| 4 | 2005 | 258 | |
| 5 | 1994 | 158 | |
| 6 | 2004 | 158 | |
| 7 | 2005 | 153 | |
| 8 | 2004 | 151 | |
| 9 | 1988 | 139 | |
| 10 | 2005 | 135 | |
| 11 | 2014 | 130 | |
| 12 | 2003 | 85 | |
| 13 | 2015 | 83 | |
| 14 | 2000 | 78 | |
| 15 | 2004 | 67 | |
| 16 | 2006 | 63 | |
| 17 | 2000 | 62 | |
| 18 | 1995 | 60 | |
| 19 | 2010 | 51 | |
| 20 | 2000 | 50 |
About Mark E. Duggan
Mark E. Duggan is a scholar working on Immunology and Allergy, Cellular and Molecular Neuroscience, Molecular Biology, Psychiatry and Mental health and Hematology, having authored 61 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (20 papers), Neuroscience and Neuropharmacology Research (16 papers), Receptor Mechanisms and Signaling (9 papers), Schizophrenia research and treatment (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Bone Metabolism and Diseases (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Chemical Synthesis and Analysis (4 papers). The work is most often cited by research in Immunology and Allergy (485 citations), Cellular and Molecular Neuroscience (612 citations), Molecular Biology (1.3k citations), Organic Chemistry (680 citations) and Computational Theory and Mathematics (259 citations). Mark E. Duggan has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include George D. Hartman, Michele H. Potashman, Craig W. Lindsley, Zhijian Zhao, Joel R. Huff, Hans E. Huber, R. Robinson, Raymond E. Jones, Deborah Defeo-Jones and Stanley F. Barnett. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Neuropharmacology, ACS Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.